All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional.
The GvHD Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy
An expert panel hosted by
Customizing first-line BTK inhibitors for CLL
with Gilles Salles, Paolo Ghia, and Francesc Bosch
Wednesday, October 23, 2024
18:30-19:30 BST
This independent educational activity is supported by Pharmacyclics LLC, an AbbVie Company and Janssen Biotech. All content is developed independently by the faculty. The funder is allowed no influence on the content of this activity.
The GvHD Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the GvHD Hub cannot guarantee the accuracy of translated content. The GvHD Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The GvHD Hub is an independent medical education platform, sponsored by Medac and supported through grants from Sanofi and Therakos. The funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.
Mohamad MohtyChair
Mohamad Mohty is a Professor of Hematology and Head of the Hematology and Cellular Therapy Department at Hôpital Saint-Antoine and Sorbonne University, Paris, FR. In addition, he is head of a translational research team (INSERM) at the Saint-Antoine Research Center, Paris, FR. Mohty obtained his medical degree from University of Montpellier, Montpellier, FR, and his PhD from Aix-Marseille University, Marseille, FR.
Mohty has been president of the European Society for Blood and Marrow Transplantation (EBMT) and is currently chair of the Acute Leukemia Working Party of the EBMT. He is also the founder and chair of the International Academy for Clinical Hematology (IACH) and board member of the EBMT and Intergroupe Francophone du Myélome (IFM).
In addition to publishing more than 900 peer-reviewed articles in the field of stem cell transplantation, leukemia, and myeloma, Mohty serves as an Editor-in-Chief of Bone Marrow Transplantation and Clinical Hematology International. He is also an editor, board member, and/or reviewer across numerous other reputable journals.